IOVA Return on Tangible Equity | IOVANCE BIOTHERAPEUTICS, INC.

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Return on Tangible Equity

2026-06-30: Return Tang Equity -61.32%.
2026-03-31: Return Tang Equity -78.18%.
2025-12-31: Return Tang Equity -93.25%.
2025-09-30: Return Tang Equity -95.34%.

Complete source-backed return tang equity history.

Available history: 2008-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-61.32%
2026-03-31	-78.18%
2025-12-31	-93.25%
2025-09-30	-95.34%
2025-06-30	-96.94%
2025-03-31	-77.79%
2024-12-31	-86.96%
2024-09-30	-87.83%
2024-06-30	-93.02%
2024-03-31	-116.57%
2023-12-31	-124.96%
2023-09-30	-96.13%
2023-06-30	-122.09%
2023-03-31	-61.73%
2022-12-31	-79.24%
2022-09-30	-99.03%
2022-06-30	-79.63%
2022-03-31	-64.93%
2021-12-31	-55.05%
2021-09-30	-44.58%
2021-06-30	-38.12%
2021-03-31	-41.00%
2020-12-31	-39.54%
2020-09-30	-35.79%
2020-06-30	-32.40%
2020-03-31	-94.61%
2019-12-31	-66.08%
2019-09-30	-46.91%
2019-06-30	-37.97%
2019-03-31	-30.81%
2018-12-31	-26.51%
2018-09-30	-45.98%
2018-06-30	-38.87%
2018-03-31	-33.46%
2017-12-31	-63.28%
2017-09-30	-49.50%
2017-06-30	-60.79%
2017-03-31	-44.50%
2016-12-31	-31.69%
2016-09-30	-25.44%
2016-06-30	-18.23%
2016-03-31	-29.56%
2015-12-31	-26.59%
2015-09-30	-22.10%
2015-06-30	-17.13%
2015-03-31	-13.50%
2014-12-31	-26.84%
2014-09-30	-115.51%
2014-06-30	-145.44%
2014-03-31	-158.25%
2013-12-31	-144.19%
2013-09-30	311.89%
2013-06-30	60.74%
2013-03-31	-11.55%
2012-12-31	29.22%
2012-09-30	91.22%
2012-03-31	118.82%
2011-12-31	121.09%
2011-09-30	137.74%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-93.25%
2024-12-31	-86.96%
2023-12-31	-124.96%
2022-12-31	-79.24%
2021-12-31	-55.05%
2020-12-31	-39.54%
2019-12-31	-66.08%
2018-12-31	-26.51%
2017-12-31	-63.28%
2016-12-31	-31.69%
2015-12-31	-26.59%
2014-12-31	-26.84%
2013-12-31	-144.19%
2012-12-31	29.22%
2011-12-31	201.03%
2010-12-31	-252.00%
2009-12-31	116.93%
2008-12-31	-2570.75%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Adaptive Biotechnologies Corp (ADPT)	United States	$4.719B	-53.43
CRISPR Therapeutics AG (CRSP)		$5.390B	-11.68
Relay Therapeutics, Inc. (RLAY)	United States	$3.884B	-14.30
Scholar Rock Holding Corp (SRRK)	United States	$5.920B	-16.37
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95
Tarsus Pharmaceuticals, Inc. (TARS)	United States	$3.329B	-58.60
Denali Therapeutics Inc. (DNLI)	United States	$3.274B	-8.04
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
Beam Therapeutics Inc. (BEAM)	United States	$2.549B	-41.51
Greenland Mines Ltd (GRML)	United States	$2.362B